New research into a possible therapy for age-related macular degeneration (AMD) is "very exciting", according to one expert.
Dr Robert Lanza is Chief Scientific Officer at Advanced Cell Technology, which is currently working on a stem cell treatment for AMD which involves using retinal pigment epithelial (RPE) cells derived from human embryonic stem cells.
As there is currently no known treatment for the disease, he said this latest study may mark the beginning of a new era of therapy for the leading cause of blindness on the planet.
"Because only a small number of cells (50-200K) are needed to treat each patient, manufacturing and distribution of the therapeutic product is scalable. Based on our animal model studies, we are very excited about the opportunity to treat patients," Dr Lanza explained.
A recent study into possible treatments for AMD the Wilmer Eye Institute at Johns Hopkins School of Medicine found that people who eat foods which are rich in omega-3 fatty acids can help to stave off the condition.
by Emily Tait